Cocrystal Pharma, Inc. (COCP)
0.98
0.00 (0.00%)
USD |
NASDAQ |
Nov 16, 16:00
0.9601
-0.02
(-2.03%)
After-Hours: 20:00
Cocrystal Pharma Price to Book Value : 12.94 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 12.94 |
| November 12, 2026 | 13.08 |
| November 11, 2026 | 13.47 |
| November 10, 2026 | 13.60 |
| November 09, 2026 | 14.59 |
| November 06, 2026 | 13.74 |
| November 05, 2026 | 13.21 |
| November 04, 2026 | 13.34 |
| November 03, 2026 | 14.13 |
| November 02, 2026 | 14.00 |
| October 30, 2026 | 13.14 |
| October 29, 2026 | 12.94 |
| October 28, 2026 | 13.08 |
| October 27, 2026 | 12.96 |
| October 26, 2026 | 12.84 |
| October 23, 2026 | 12.55 |
| October 22, 2026 | 12.05 |
| October 21, 2026 | 12.46 |
| October 20, 2026 | 12.45 |
| October 19, 2026 | 12.50 |
| October 16, 2026 | 13.47 |
| October 15, 2026 | 13.60 |
| October 14, 2026 | 13.74 |
| October 13, 2026 | 14.26 |
| October 12, 2026 | 14.00 |
| Date | Value |
|---|---|
| October 09, 2026 | 14.13 |
| October 08, 2026 | 14.13 |
| October 07, 2026 | 14.00 |
| October 06, 2026 | 14.66 |
| October 05, 2026 | 14.66 |
| October 02, 2026 | 15.12 |
| October 01, 2026 | 15.06 |
| September 30, 2026 | 15.19 |
| September 29, 2026 | 14.79 |
| September 28, 2026 | 15.98 |
| September 25, 2026 | 15.45 |
| September 24, 2026 | 15.19 |
| September 23, 2026 | 15.72 |
| September 22, 2026 | 15.72 |
| September 21, 2026 | 15.72 |
| September 18, 2026 | 15.98 |
| September 17, 2026 | 15.06 |
| September 16, 2026 | 15.06 |
| September 15, 2026 | 15.06 |
| September 14, 2026 | 15.45 |
| September 11, 2026 | 16.38 |
| September 10, 2026 | 16.25 |
| September 09, 2026 | 16.38 |
| September 08, 2026 | 15.59 |
| September 04, 2026 | 14.92 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.8618 |
| Fulcrum Therapeutics, Inc. | 0.9433 |
| Definium Therapeutics, Inc. | 4.262 |
Price to Book Value Related Metrics
| PS Ratio | 38.87 |
| Price | 0.98 |
| Earnings Yield | -77.42% |
| Market Cap | 13.51M |